期刊文献+

胎儿染色体非整倍体无创基因检测试剂盒的临床验证 被引量:5

Clinical validation of noninvasive genetic testing kit of fetal chromosomal aneuploidy
原文传递
导出
摘要 目的验证胎儿染色体非整倍体(T21、T18、T13)基因检测试剂盒(联合探针锚定连接测序法)在临床检测上的准确性和有效性。方法选择广东省东莞市妇幼保健院的孕妇外周血样本,采用胎儿染色体非整倍体(T21、T18、T13)基因检测试剂盒通过联合探针锚定连接测序法检测,并将结果与临床诊断金标准染色体核型分析结果或出生随访结果作对比。对灵敏度、特异性、总符合率和一致性系数Kappa值进行评价,以验证该试剂盒在临床检测上的准确性和有效性。结果共完成有效样本389例,测序法检出T21阳性6例,T18和T13均未检出阳性,与染色体核型分析结果相符,检测为阴性共383例,经电话随访至出生未发现非整倍体胎儿。统计分析结果显示,测序法与核型分析法总符合率为100%,Kappa=1(≥0.8),其中检测T21的灵敏度、特异性、阳性预测值、阴性预测值均为100%;检测T18和T13的特异性、阴性预测值均为100%。结论采用试剂盒通过联合探针锚定连接测序法检测T21、T18、T13的结果准确度高且方法安全,可以在临床上推广使用。 Objective To verify the accuracy and effectiveness of a genetic detection kit for noninvasive fetal trisomy( T21,T18 and T13,based on combinatorial probe-anchor ligation sequencing,a product of BGI Biotechnology Limited Co.) in clinical practice. Methods Pregnant women who underwent prenatal diagnosis in our hospital were recruited in this study. Maternal peripheral blood samples were collected from each participant,and then processed in accordance with the kit instructions followed by combinatorial probe-anchor ligation sequencing. The results were compared with the results from prenatal karyotyping confirmation and baby born. The sensitivity,specificity,overall compliance rate and consistency coefficient Kappa values were evaluated to verify the accuracy and validity of the kit in the clinical testing.Results A total of 389 valid samples was tested using this genetic testing kit. Six pregnant women were found carrying trisomy 21 fetuses by sequencing,and none of them carrying trisomy 18 or 13 fetus,which consistent with the results of karyotyping. The other 383 women were negative,which was further validated by telephone follow-up after baby born. Statistical analysis showed that the total coincidence rate of our sequencing and karyotyping was 100% and the Kappa = 1( ≥ 0. 8), indicating that the sensitivity,specificity,positive predictive value and negative predictive value of trisomy 21 were 100%, and the specificity,negative predictive value of trisomy 18 and trisomy 13 were 100%. Conclusion This genetic detection kit for noninvasive fetal trisomy is of high accuracy and security,and should be worth of extensive application in clinic.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2016年第1期97-100,共4页 Journal of Third Military Medical University
基金 东莞市医学重点资助项目(2013108101021) 广东省省级科技计划项目(2013B022000003)~~
关键词 试剂盒 非整倍体 联合探针锚定连接测序法 胎儿游离DNA 产前诊断 testing kits aneuploidy combinatorial probe anchor attachment sequencing cell free DNA prenatal diagnosis
  • 相关文献

参考文献20

  • 1张月萍,伍俊萍,李笑天,雷彩霞,徐建忠,殷民.孕中期羊水细胞染色体核型分析及其异常核型发生率的比较[J].中华妇产科杂志,2011,46(9):644-648. 被引量:40
  • 2Nicopoullos J D, Gilling-Smith C, Almeida P A, et al. The role of sperm aneuploidy as a predictor of the success of intra- cytoplasmic sperm injection? [J]. Hum Reprod, 2008, 23 (2) : 240 -250. DOI: 10. 1093/humrep/dem395.
  • 3王斌,陈英耀,石琦,张洁,李军,钱序,朱怡蓓.我国唐氏综合征的疾病经济负担研究[J].中国卫生经济,2006,25(3):24-26. 被引量:91
  • 4Williams E S, Cornforth M N, Goodwin E H, et al. CO- FISH, COD-FISH, ReD-FISH, SKY-FISH[ J]. Methods Mol Biol, 2011, 735:113 -124. DOI: 10. 1007/978-1-61779- 092-8_11.
  • 5Leung T Y, Voqel I, Lau T K, et al. Identification of submi- croscopic chromosomal aberrations in fetuses with increased nuchal translucency and apparently normal karyotype[ J 1- Ul- trasound Obstet Gynecol, 2011, 38 (3) : 314 - 319. DOI: 10. lO02/uog. 8988.
  • 6Vermeesch J R, Fiegler H, de-Leeuw N, et al. Guidelines for molecular karyotyping in constitutional genetic diagnosis [J]. Eur J Hum Genet, 2007, 15(11) : 1105 - 1114.
  • 7产前诊断技术管理办法[J].中国生育健康杂志,2003,14(2):68-70. 被引量:21
  • 8ACOG Committee on Practice Bulletins. ACOG Practice Bul- letin No. 77: screening for fetal chromosomal abnormalities [J]. Obstet Gynecol, 2007, 109(1): 217-227.
  • 9Driscoll D A, Gross S J, Professional Practice GuidelinesCommittee. Screening for fetal aneuploidy and neural tube de- fects[J]. GenetMed, 2009, 11(11):818-821. DOI: 10. 1097/GIM. 0b013 e3181 bb267b.
  • 10Benn P A, Fang M, Egan J F, et al. Incorporation of inhib- in-A in second-trimester screening for Down syndrome [ J ]. Obstet Gynecol, 2003, 101 (3) : 451 - 454.

二级参考文献16

  • 1张月萍,徐建忠,殷民,陈美芳,任德麟.染色体平衡易位携带者妊娠风险及妊娠结局的研究[J].中华妇产科杂志,2006,41(9):592-596. 被引量:38
  • 2Shaffer LG, Slovak ML, Campbell LJ. ISCN 2009:an international system for human cytogenetic nomenclature(2009):recommendations of the international standing committee on human eytogenetic nomenclature. New York:Karger,2009:25-30.
  • 3Bornstein E,Lenchner E,Donnenfeld A,et al. Advanced maternal age as a sole indication for genetic amnioeentesis; riskbenefit analysis based on a large database reflecting the current common practice.J Perinat Med,2009,37:99-102.
  • 4Karaoguz MY,Bal F,Yakut T,et al.Cytogenetic results of amniocentesis materials:incidence of abnormal karyotypes in the Turkish collaborative study.Genet Couns,2006,17:219-230.
  • 5Gonzalez-Merino E,Hans C,Abramowicz M,et al.Aneuploidy study in sperm and preimplantation embryos from nonmosaic 47,XXY men.Fertil Steril,2007,88:600-606.
  • 6Gardner RJM, Sutherland GR. Down syndrome, other full aneuploidies,and polyploidy//Gardner RJM, Sutherland GR.Chromosome abnormalities and genetic counseling.2nd ed.New York:Oxford,1996:243-258.
  • 7Bagherizadeh E,Oveisi M,Hadipour Z,et al.Triploidy in a fetus following amniocentesis referred for maternal serum screening test at second trimester.Indian J Hum Genet,2010,16:94-96.
  • 8Giardino D,Corti C, Ballarati L,et al. De novo balanced chromosome rearrangements in prenatal diagnosis.Prenat Diagn,2009,29:257-265.
  • 9Adeyinka A,Smoley S,Fink S,et al.Isochromosome (X) (p10)in hematologic disorders:FISH study of 14 new cases show three types of centromere signal patterns. Cancer Genet Cytogenet,2007,179:25-30.
  • 10Warburton D.De novo balanced chromosome rearrangements and extra marker chromosomes identified at prenatal diagnosis:clinical significance and distribution of breakpoints.Am J Hum Genet,1991,49:995-1013.

共引文献149

同被引文献28

引证文献5

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部